Enhancement of doxorubicin-induced antitumor activity and reduction of adverse reactions by cucurbitacin I

► In cancer chemotherapy, the improvement by food components was hoped. ► Cucurbitacin I increased antitumor activity by DOX via suppressed efflux of DOX. ► Cucurbitacin I decrease DOX induced adverse reaction.